Intimal Hyperplasia: Evolving Concepts of Pathophysiology and Therapy

Szilagyi DE , Smith RF , Elliott JP , Allen HM Long-term behavior of a Dacron arterial substitute: Clinical, roentgenologic and histologic correlations. Ann Surg 162:453-477, 1965.

Imparato AM , Bracco A. , Kim GE , Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions . Surgery 72:1007-1017, 1972 .

Echave V. , Koornick AR , Haimov M. , Jacobson JH II. Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoral-popliteal bypass. Surgery 86: 791-798, 1979.

Eickhoff JH , Broomé A. , Ericson BF , Hanson HJB , Kordt KF , Mouritzen C. , Kvernebo K. , Norgren L. , Rostad H. , Trippestad A. Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg 6:506-511, 1987.

Veith FJ , Gupta SK , Ascer E. , White-Flores S. , Samson RH , Scher LA , Towne JB , Bernhard VM , Bonier PH , Flinn WR , Astelford RN , Yao JST , Bergan JJ Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3:104-114, 1986.

Taylor LM Jr , Edwards JM , Phinney ES , Porter JM Reversed vein bypass to infrapopliteal arteries. Modern results are superior to or equivalent to in-situ bypass for patency and for vein utilization. Ann Surg 205:90-97, 1987.

Palder SR , Kirkman RL , Whittemore AD , Hakim RM , Lazarus JM , Tilney NL Vascular access for hemodialysis. Patency rates and results of revision . Ann Surg 202:235-239, 1985.

Faxon DP , Sanborn TA , Weber VJ , Haudenschild CC , Gottsman SB , McGovern WA , Ryan TJ Restenosis following transluminal angioplasty in experimental atherosclerosis . Arteriosclerosis 4:189-195, 1984.

Mosse PR , Campbell GR , Campbell JH Smooth muscle phenotype expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. Arteriosclerosis 6:664-669, 1986.

Zarins CK , Zatine MA , Giddens DP , Ku DN , Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis . J Vasc Surg 5:413-420, 1987.

Levine AW , Bandyk DF , Bonier PH , Towne JB Lessons learned in adopting the in situ saphenous vein bypass. J Vasc Surg 2:145-153, 1985.

Adcock GD , Adcock OT , Wheeler JR , Gregory RT , Snyder SO Jr , Gayle RG , Trivedi AN Arterialization of reversed autogenous vein grafts: Quantitative light and electron microscopy of canine jugular vein grafts harvested and implanted by standard or improved techniques. J Vasc Surg 6:283-295, 1987.

LoGerfo FW , Haudenschild CC , Quist WC A clinical technique for prevention of spasm and preservation of endothelium in saphenous vein grafts. Arch Surg 119:1212-1214, 1984.

Brody JI , Pickering NJ , Fink GB Immunocytochemical features of obstructed saphenous vein—coronary artery bypass grafts. J Clin Pathol 42:477-482, 1989.

LoGerfo FW , Quist WC , Nowak MD , Cranshaw HM , Haudenschild CC Downstream anastomotic hyperplasia: A mechanism of failure in Dacron arterial grafts. Ann Surg 197: 479-483, 1983.

De Groote RD , Lynch TG , Jamil Z. , Hobson RW II. Carotid restenosis: Long-term noninvasive follow-up after carotid endarterectomy. Stroke 18:1031-1036, 1987.

Claggett GP , Robinowitz M. , Youkey JR , Fisher DF Jr , Fry RE , Myers S. , Lee EL , Collins GJ Jr , Virmani R. Morphogenesis and clinicopathologic characteristics of recurrent carotid disease. J Vasc Surg 3:10-23, 1986.

McBride W. , Lange RA , Hillis LD Restenosis after successful coronary angioplasty. N Engl J Med 318:1734-1737, 1988.

Walker LN , Reidy MA , Bowyer DE Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am J Pathol 125:450-459, 1986.

Silverberg E. , Lubera JA Cancer statistics, 1988. CA 38:5-22, 1988.

Ross R. The pathogenesis of atherosclerosis—An update. N Engl J Med 314:488-500, 1986.

Ross R. , Glomset JA Atherosclerosis and the arterial smooth muscle cell. Science 180: 1332-1339, 1973.

Ross R. Mechanisms of smooth muscle proliferation—The role of cytokines and growth factors. In Research Initiatives in Vascular Disease—Intimal Hyperplasia. Paper presented at National Institutes of Health Symposia, Washington, DC, March 9-10, 1989.

Clowes AW , Gown AM , Hanson SR , Reidy MA Mechanisms of arterial graft failure. I. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol 118:43-54, 1985.

Sumpio BE , Banes AJ , Johnson G. Enhanced collagen production by smooth muscle cells during mechanical stretching . Arch Surg 123:1233-1236, 1988 .

Sumpio BE , Banes AJ Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery 104:383-389, 1988.

Clowes AW , Kirkman TR , Clowes MM Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses . J Vasc Surg 3:877-884, 1986.

Bowen-Pope DF , Malpass TW , Foster DM , Ross R. Platelet-derived growth factor in vivo: Levels, activity, and fate of clearance. Blood 64:458-469, 1984.

Ross R. Platelet-derived growth factor. Annu Rev Med 38:71-79, 1987.

Birinyi LK , Warner SJC , Salomon RN , Callow AD , Libby P. Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: Production of a platelet-derived growth factor—like mitogen and expression of a gene for a PDGF receptor—A preliminary study . J Vasc Surg 10:157-165, 1989.

Libby P. , Warner SJC , Salomon RN , Birinyi LK Production of platelet-derived growth factor—like mitogen by smooth muscle cells from human atheromata. N Engl J Med 318: 1493-1498, 1988.

Barrett TB , Benditt EP sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA 84:1099-1103, 1987 .

Barrett TB , Benditt EP Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 85:2810-2814, 1988.

Wilcox JN , Smith KM , Williams LT , Schwartz SM , Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 82:1134-1143, 1988.

DiCorleto PE , Bowen-Pope DF Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA 80:1919-1923, 1983.

Barrett TB , Gajdusek CM , Schwartz SM , McDougall JK , Benditt EP Expression of the sis gene by endothelial cells in culture and in vivo. Proc Natl Acad Sci USA 81:6772-6774, 1984 .

Martinet Y. , Rom WN , Grotendorst GR , Martin GR , Crystal RG Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 317:202-209, 1987.

Collins T. , Ginsburg D. , Boss JM , Orkin SH , Pober JS Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316:748-750, 1985.

Majesky MW , Benditt EP , Schwartz SM Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci USA 85:1524-1528, 1988 .

Sejersen T. , Betsholtz C. , Sjolund M. , Heldin C-H. , Westermark B. , Thyberg J. Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. Proc Natl Acad Sci USA 83:6844-6848, 1986 .

Sjölund M. , Hedin U. , Sejersen T. , Heldin C-H. , Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype and growth state dependent manner. J Cell Biol 106:403-413, 1988.

Shimokado K. , Raines EW , Madtes DK , Barrett TB , Benditt EP , Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF . Cell 43:277-286, 1985.

Martinet Y. , Bitterman PB , Mornex JF , Grotendorst GR , Martin GR , Crystal RG Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature 319:158-160, 1986.

Thornton MA , Gruentzig AR , Hollman J. , King SB III , Douglas JS Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 69:721-727, 1984.

Schmitt DD , Bandyk DF , Towne JB , Seabrook GR Monitoring functional patency of in situ saphenous vein bypasses: The impact of a surveillance protocol and elective revision. J Vasc Surg 9:286-296, 1989.

Bang HO , Dyerberg J. , Nielsen AB Plasma lipids and lipoprotein patterns in Greenlandic west-coast Eskimos . Lancet 1:1143-1146, 1971 .

Fox PL , DiCorleto PE Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 241:453-456, 1988.

Sarris GE , Fann JI , Sokoloff MH , Smith DL , Loveday M. , Kosek JC , Cooper AD , May K. , Willis AL , Miller DC Mechanism of fish oil inhibition of canine vein graft arteriosclerosis . Circulation 78 (Suppl II):II-234, 1988.

Landymore RW , MacAulay M. , Sheridan B. , Cameron C. Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. Ann Thorac Surg 41:54-57, 1986.

Sarris GE , Mitchell RS , Billingham ME , Glasson JR , Cahill PD , Miller DC Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thorac Cardiovasc Surg 97:841-854, 1989.